drugset / Trial / NCT02998554

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo

NCT02998554 ↗

Phase 3 Terminated 156 enrolled Shire
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if an investigational treatment is effective compared with placebo in the treatment of adults and children with adenoviral conjunctivitis.

Timeline

Start
2017-03-28
Primary completion
2019-05-16
Completion
2019-05-16

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision, unrelated to safety”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 % Other
Subject Povidone-Iodine Other / unclassified 0.6 % Other

Indications